When governments fund biomedical R&D, the contractual provisions in the funding agreement are important, as regard's the public's rights in the outcomes. These contracts should be public.

Transparency is even more important when core public interest clauses are not standardized.

Transparency of the contracts should not be a partisan issue. It makes the system work better, and makes governments more accountable.
Standard clauses, or norms, for public sector contracts are useful, and can make the process more efficient. Exceptions to the standard clauses can be provided, but the process for an exception is important. Governments should be transparent as to why they want to make an exception,. and depending on the issue, consider public feedback first.